Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Absorption of paroxetine under various dietary conditions and following antacid intake.

Greb WH, Brett MA, Buscher G, Dierdorf HD, von Schrader HW, Wolf D, Mellows G, Zussman BD.

Acta Psychiatr Scand Suppl. 1989;350:99-101. No abstract available.

PMID:
2530802
2.

The effect of liver enzyme inhibition by cimetidine and enzyme induction by phenobarbitone on the pharmacokinetics of paroxetine.

Greb WH, Buscher G, Dierdorf HD, Köster FE, Wolf D, Mellows G.

Acta Psychiatr Scand Suppl. 1989;350:95-8. No abstract available.

PMID:
2530801
3.

The pharmacokinetics of paroxetine in patients with liver cirrhosis.

Krastev Z, Terziivanov D, Vlahov V, Maleev A, Greb WH, Eckl KM, Dierdorf HD, Wolf D.

Acta Psychiatr Scand Suppl. 1989;350:91-2. No abstract available.

PMID:
2530799
4.

Ability of charcoal to prevent absorption of paroxetine.

Greb WH, Buscher G, Dierdorf HD, von Schrader HW, Wolf D.

Acta Psychiatr Scand Suppl. 1989;350:156-7. No abstract available.

PMID:
2530777
5.

Determination of paroxetine in human plasma, using high-performance liquid chromatography with fluorescence detection.

Brett MA, Dierdorf HD, Zussman BD, Coates PE.

J Chromatogr. 1987 Aug 7;419:438-44. No abstract available.

PMID:
2959675

Supplemental Content

Loading ...
Support Center